Saturday, July 11, 2026

Drug profile · INN

derivative

derivative is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 3
News articles 0
Drug details — derivative
Class
Route
Patents
20
Programs
3
Data quality
0.70

Quick answer

derivative is an FDA-listed pharmaceutical active ingredient.

Key facts

INN derivative

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative Phase 2 · Chinese Academy of · Tuberculosis
  2. Spray of spirulina derivatives Phase 2 · Chinese Academy of · Radiation-induced Oral Mucositis
  3. Purified Protein Derivative of BCG(BCG-PPD) Phase 1 · Anhui Huaheng Biotechnology · Tuberculosis

Related patents

  1. US 20260146049

    SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER

    Expires Wed May 23 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. AU 2024342196

    NOVEL ECTEINASCIDIN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

    Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. AU 2024268154

    NOVEL CARBOXAMIDE DERIVATIVES

    Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12428403

    N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12428408

    Fused heterocyclic mescaline derivatives

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12421231

    Azaindole derivatives and their use as ERK kinase inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12421228

    Naphthyridine derivatives as PRC2 inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12421236

    Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12403136

    Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12404237

    Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12398179

    Nanomolar peptides and derivatives to differentially modulate ephrin receptors

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 12396989

    Nicorandil derivatives

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 12398131

    Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 12391642

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 12378241

    Pyridine derivative as FGFR and VEGFR dual inhibitors

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 12377082

    Nicorandil derivatives

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 12378195

    Aminated psilocybin derivatives and methods of using

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 12370192

    Azole-fused pyridazin-3(2H)-one derivatives

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 12358885

    Substituted n-propylamine fused heterocyclic mescaline derivatives

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 12338231

    N-heterocycle substituted tryptamine derivatives and methods of using

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is derivative?

derivative is an FDA-listed pharmaceutical active ingredient.